http://www.portexminerals.com/presentations/Toral-NI-43-101-technical-report-april-30-2012.pdf bit of background. Portex bought in April 2012 but ran out of cash and struggled forcing the sale late 2015 to the Swiss middlemen.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%